Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK1 | Q15118 | 1/20 | 0.62 |
| ▸ | DRD3 | P35462 | 5/20 | 0.55 |
| ▸ | DRD2 | P14416 | 4/20 | 0.55 |
| ▸ | HRH2 | P25021 | 2/20 | 0.55 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.55 |
| ▸ | DRD4 | P21917 | 2/20 | 0.55 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.55 |
| ▸ | HTR1A | P08908 | 1/20 | 0.55 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.55 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.55 |
| ▸ | HTR1B | P28222 | 1/20 | 0.55 |
| ▸ | HTR2A | P28223 | 1/20 | 0.55 |
| ▸ | HTR7 | P34969 | 1/20 | 0.55 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.55 |
| ▸ | HRH1 | P35367 | 1/20 | 0.55 |
| ▸ | HTR2B | P41595 | 1/20 | 0.55 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.55 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 4/20 | 0.54 |
| ▸ | LMNA | P02545 | 3/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5204000 | 0.85 | APOBEC3A (0.48) | PDK1DRD3DRD2HRH2ADRA2A | |
| SCHEMBL2051128 | 0.79 | LMNA (0.55) | DRD3DRD2HRH2ADRA2ADRD4 | |
| SCHEMBL306889 | 0.79 | LMNA (0.55) | DRD3DRD2HRH2ADRA2ADRD4 | |
| SCHEMBL10264578 | 0.79 | PDK1 (0.64) | PDK1MAPTLMNAHSD17B10GAA | |
| SCHEMBL306888 | 0.79 | LMNA (0.55) | DRD3DRD2HRH2ADRA2ADRD4 | |
| Hydrochloric Acid SCHEMBL942873 | 0.78 | LMNA (0.54) | DRD3DRD2HRH2ADRA2ADRD4 | |
| SCHEMBL8209089 | 0.78 | LMNA (0.54) | DRD3DRD2HRH2ADRA2ADRD4 | |
| SCHEMBL6865505 | 0.78 | LMNA (0.54) | DRD3DRD2HRH2ADRA2ADRD4 | |
| Bromide SCHEMBL1193429 | 0.78 | LMNA (0.54) | DRD3DRD2HRH2ADRA2ADRD4 | |
| Hydrochloric Acid SCHEMBL1032722 | 0.78 | LMNA (0.54) | DRD3DRD2HRH2ADRA2ADRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115976584-B | Copper electroplating solution suitable for filling ultra-deep hole TSV and copper electroplating process thereof | 深圳创智芯联科技股份有限公司 | 2025-01-28 | — | — | CN | claimed |
| CN-115976584-A | Copper electroplating solution suitable for filling ultra-deep hole TSV and copper electroplating process thereof | 深圳创智芯联科技股份有限公司 | 2023-04-18 | — | — | CN | claimed |
| CN-115976584-B | Copper electroplating solution suitable for filling ultra-deep hole TSV and copper electroplating process thereof | 深圳创智芯联科技股份有限公司 | 2025-01-28 | — | — | CN | disclosed |
| CN-115976584-B | Copper electroplating solution suitable for filling ultra-deep hole TSV and copper electroplating process thereof | 深圳创智芯联科技股份有限公司 | 2025-01-28 | — | — | CN | disclosed |
| US-20240409533-A1 | HMOX1 INDUCERS | Astellas Engineered Small Molecules US, Incorporated | 2024-12-12 | — | — | US | disclosed |
| CN-113874074-B | HMOX1 inducers | 米托布里奇公司 | 2024-11-01 | — | — | CN | disclosed |
| US-12071433-B2 | HMOX1 inducers | Astellas Engineered Small Molecules US, Incorporated (US) | 2024-08-27 | — | — | US | disclosed |
| US-20240051952-A1 | HMOX1 INDUCERS | Astellas Engineered Small Molecules US, Incorporated | 2024-02-15 | — | — | US | disclosed |
| CN-115976584-A | Copper electroplating solution suitable for filling ultra-deep hole TSV and copper electroplating process thereof | 深圳创智芯联科技股份有限公司 | 2023-04-18 | — | — | CN | disclosed |
| CN-115976584-A | Copper electroplating solution suitable for filling ultra-deep hole TSV and copper electroplating process thereof | 深圳创智芯联科技股份有限公司 | 2023-04-18 | — | — | CN | disclosed |
| US-20230038589-A1 | Methods and compositions for targeting Tregs using CCR8 inhibitors | Nanjing Immunophage Biotech Co., Ltd. (CN) | 2023-02-09 | — | — | US | disclosed |
| US-20130079323-A1 | GYRASE INHIBITORS | TRIUS THERAPEUTICS, INC. (US) | 2013-03-28 | — | — | US | disclosed |
| EP-2548877-A1 | 4-(5-Membered fused pyridinyl)benzamides as BTK-inhibitors | MSD Oss B.V. (NL) | 2013-01-23 | — | — | EP | disclosed |
| US-20110190356-A1 | Compositions and Methods of Using (R)- Pramipexole | KNOPP NEUROSCIENCES INC. (US) | 2011-08-04 | — | — | US | disclosed |
| US-7868029-B2 | Process for the preparation of 2-amino-4,5,6,7-tetrahydro-6-aminobenzothiazoles from cyclohexanes and cyclohexanones as intermediates | GENERICS [UK] LIMITED (GB) | 2011-01-11 | — | — | US | disclosed |
| EP-1343561-B1 | SERINE PROTEASE INHIBITORS | TULARIK LTD (GB) | 2007-02-28 | — | — | EP | disclosed |
| EP-1343561-A1 | SERINE PROTEASE INHIBITORS | Tularik Limited (GB) | 2003-09-17 | — | — | EP | disclosed |
| WO-2003048155-A1 | THROMBIN INHIBITORS | UNIVERSITY OF LJUBLJANA (SI) | 2003-06-12 | — | — | WO | disclosed |
| WO-2002047762-A1 | SERINE PROTEASE INHIBITORS | TULARIK LIMITED (GB) | 2002-06-20 | — | — | WO | disclosed |
| US-4321372-A | Antiulcer thiazol-2-ylcarbamoyl-carboxylic acids, esters and amides | PFIZER INC. (US) | 1982-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130079323-A1 | GYRASE INHIBITORS | TOP1, CA7, TOP2B | PDK1 3170/4885DRD3 3169/4885DRD2 4210/4885 |
| US-20240409533-A1 | HMOX1 INDUCERS | HMOX1, HMOX2, HMBS | PDK1 2257/4885DRD3 3047/4885DRD2 3598/4885 |
| US-12071433-B2 | HMOX1 inducers | HMOX1, HMOX2, HMBS | PDK1 1876/4885DRD3 3565/4885DRD2 3953/4885 |
| US-20240051952-A1 | HMOX1 INDUCERS | HMOX1, HMOX2, QSOX1 | PDK1 2672/4885DRD3 3045/4885DRD2 3677/4885 |
| US-20230038589-A1 | Methods and compositions for targeting Tregs using CCR8 inhibitors | CCR8, CCR1, CCR3 | PDK1 4218/4885DRD3 3789/4885DRD2 4540/4885 |
| US-20110190356-A1 | Compositions and Methods of Using (R)- Pramipexole | HSPE1, GRIN2B, GRIN2A | PDK1 260/4885DRD3 2284/4885DRD2 1704/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.